[Elsevier] Antibody每drug conjugates after EGFR-TKI resistance in EGFR-mutant NSCLC: Evidence boundaries, post-progression reassessment, and therapeutic sequencing

Eyaddddddddd Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-29 03:27
Reward30points

journalㄩCritical Reviews in Oncology/Hematology

AuthorsㄩLinlin Wang; Yong Feng; Renxiang Jia; Qiang Liu

Published dateㄩ2026-10-

DOIㄩ10.1016/j.critrevonc.2026.105661

PDF linkㄩhttps://www.sciencedirect.com/sc ... 040842826005482/pdf

Article linkㄩhttps://doi.org/10.1016/j.critrevonc.2026.105661

Article SourceㄩElsevier BV﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    50


Daily Top Contributors

Return to the list